Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Quality Index
Zhejiang Huahai Pharmaceutical Co Ltd cash flow quality index. Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow Quality Index of 1.56x as of June 2025. Operating cash flow of CN¥174.53 Million exceeds net income of CN¥112.08 Million, indicating high earnings quality where cash backs reported profits. Explore 600521 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Cash flow quality index of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. Historical Cash Flow Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. See how leveraged is Zhejiang Huahai Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2001–2025)
Zhejiang Huahai Pharmaceutical Co Ltd cash flow quality index by year from 2001 to 2025. Year-by-year earnings quality comparison for Zhejiang Huahai Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang Huahai Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.62x | CN¥1.23 Billion | CN¥266.40 Million | ▲ +135.4% |
| 2024 | 1.96x | CN¥2.17 Billion | CN¥1.11 Billion | ▼ -26.5% |
| 2023 | 2.67x | CN¥2.22 Billion | CN¥830.47 Million | ▲ +152.6% |
| 2022 | 1.06x | CN¥1.24 Billion | CN¥1.18 Billion | ▼ -45.9% |
| 2021 | 1.95x | CN¥938.43 Million | CN¥480.64 Million | ▲ +24.8% |
| 2020 | 1.56x | CN¥1.56 Billion | CN¥994.60 Million | ▼ -45.9% |
| 2019 | 2.89x | CN¥1.75 Billion | CN¥606.83 Million | ▲ +474.3% |
| 2018 | 0.50x | CN¥67.90 Million | CN¥134.90 Million | ▼ -42.5% |
| 2017 | 0.88x | CN¥546.24 Million | CN¥623.59 Million | ▼ -7.6% |
| 2016 | 0.95x | CN¥433.10 Million | CN¥456.90 Million | ▲ +112.0% |
| 2015 | 0.45x | CN¥195.31 Million | CN¥436.72 Million | ▼ -65.1% |
| 2014 | 1.28x | CN¥328.61 Million | CN¥256.73 Million | ▼ -5.1% |
| 2013 | 1.35x | CN¥490.29 Million | CN¥363.42 Million | ▲ +87.3% |
| 2012 | 0.72x | CN¥243.83 Million | CN¥338.49 Million | ▼ -21.9% |
| 2011 | 0.92x | CN¥197.51 Million | CN¥214.09 Million | ▼ -71.2% |
| 2010 | 3.20x | CN¥299.47 Million | CN¥93.53 Million | ▲ +65.8% |
| 2009 | 1.93x | CN¥317.44 Million | CN¥164.39 Million | ▲ +243.7% |
| 2008 | 0.56x | CN¥84.20 Million | CN¥149.86 Million | ▼ -45.7% |
| 2007 | 1.03x | CN¥136.52 Million | CN¥132.05 Million | ▲ +46.8% |
| 2006 | 0.70x | CN¥77.54 Million | CN¥110.07 Million | ▲ +70.5% |
| 2005 | 0.41x | CN¥53.30 Million | CN¥128.99 Million | ▼ -69.9% |
| 2004 | 1.37x | CN¥163.73 Million | CN¥119.13 Million | ▲ +129.9% |
| 2003 | 0.60x | CN¥47.41 Million | CN¥79.29 Million | ▼ -59.8% |
| 2002 | 1.49x | CN¥75.34 Million | CN¥50.61 Million | ▲ +69.6% |
| 2001 | 0.88x | CN¥37.51 Million | CN¥42.72 Million | — |